This interview is with Vasili Razhnou, Founder and CEO at MEDvidi.
Vasili Razhnou, Co-founder and CEO, MEDvidi
Can you introduce yourself and share your background in telehealth and mental health care, particularly as it relates to treating conditions like ADHD and anxiety?
I’m Vasili Razhnou, and I’ve spent the past 15-plus years building and operating healthcare businesses with a strong focus on mental health care. My background is in economics, but my entire professional career has been in healthcare delivery and telemedicine.
Over the years, I’ve worked closely with hundreds of mental health providers and have been deeply involved in the clinical operations behind treating conditions like ADHD, anxiety, depression, and related disorders. This includes supporting clinicians, reviewing care models, and ensuring treatment quality across high volumes of patients.
A major part of my work has been developing technology and software solutions designed specifically for mental health providers – tools that improve clinical performance, streamline workflows, and support more consistent, high-quality treatment outcomes. Because of this, I’ve had extensive exposure to ADHD and anxiety cases from both the operational and patient journey perspectives.
Overall, my experience sits at the intersection of telehealth operations, mental health care delivery, and building technology that helps providers treat patients more effectively.
What inspired you to specialize in telehealth and telemedicine for mental health, and how has your career journey shaped your approach to treating ADHD and anxiety remotely?
I moved into telehealth and telemedicine for mental health after years of operating traditional brick-and-mortar clinics and seeing firsthand how difficult it was for many patients – especially those with ADHD and anxiety – to access consistent care. The people who needed support the most were often the ones who struggled with logistics, wait times, and the complexity of the healthcare system. It became obvious to me that a digital-first approach could remove many of these barriers if it was built intentionally.
My background running outpatient clinics shaped my perspective. I’ve always looked at care through an operational and systems lens – how to make treatment more structured, reliable, and scalable without losing clinical quality. Over the years, working closely with hundreds of mental health providers and supporting thousands of patients with ADHD and anxiety has given me a deep understanding of what good remote care should look like.
In telehealth, I’ve focused on designing clear, stepwise evaluation processes, strong expectations around treatment plans and medication use, and highly structured follow up. I’ve also spent many years developing software tools that support clinicians – from charting and review systems to reminders and workflow automation – so that remote treatment for ADHD and anxiety can be both accessible and clinically responsible.
Based on your experience providing mental health care through telehealth platforms, what are the most significant advantages you’ve observed when treating patients with ADHD or anxiety virtually compared to traditional in-person sessions?
I’m not a clinician, so I don’t diagnose or treat patients. My experience is on the operational and systems side, supporting licensed providers who deliver that care. From that perspective, the biggest advantages I’ve seen with virtual care for ADHD and anxiety come from accessibility and structure.
Patients who struggle with focus, time management, or anxiety often have the hardest time keeping in-person appointments. Telehealth removes a lot of that friction – no travel, shorter wait times, and much easier follow-up. Providers also benefit from having digital tools that standardize evaluations, track symptoms, and guide ongoing care. When the operational framework is strong, it supports clinicians in delivering more consistent and timely treatment.
What’s one specific challenge you’ve encountered when diagnosing or treating ADHD through telemedicine, and what practical strategy did you develop to overcome it that other practitioners could apply?
While I’m not involved in diagnosing or treating patients myself, one major operational challenge we’ve seen around ADHD in telemedicine is variability in the information patients share during their first visit. ADHD requires a very detailed history, and inconsistent reporting can slow down the process for clinicians.
What we found effective is creating structured, pre-visit workflows – detailed symptom questionnaires, functional impairment checklists, and history prompts that patients complete before they meet with a provider. This gives clinicians a clearer baseline to work from and keeps the visit focused and efficient. Any organization can implement a similar approach: standardize intake, collect information early, and reduce the cognitive load on both patient and provider during the actual session.
For mental health professionals who are hesitant to transition to telemedicine for complex conditions like ADHD, what advice would you give them based on lessons you’ve learned in your own practice?
From the operational side, the biggest lesson has been that telemedicine works best when it’s built intentionally, not treated as a simple “video replacement” for an office visit. Providers who are hesitant often worry they won’t have enough structure or visibility in a virtual environment.
My advice is to create clear workflows: standardized evaluations, consistent follow-up intervals, and strong documentation tools. When clinicians have predictable systems supporting them, telemedicine feels far more manageable. Many providers who were initially cautious ended up preferring virtual care once they saw how much efficiency and flexibility it offers – especially for patients who traditionally struggle to stay engaged.
What emerging trends or technologies in telehealth are you most excited about for the future of mental health care, particularly for underserved populations struggling with anxiety and ADHD?
What excites me most is the evolution of AI tools that support clinicians by removing the administrative burden that traditionally slows down mental health care. In our work, we’ve developed a suite of AI systems – including an AI chart reviewer, AI assistant, AI scribe, AI chart generator, and an AI prescriber assistant – all designed to streamline the operational side of care while leaving medical judgment entirely to licensed providers.
These technologies help with tasks like preparing charts, flagging missing information, checking for potential side-effect concerns, identifying billing inconsistencies, standardizing documentation, and ensuring adherence to internal protocols. They also assist with non-clinical risk signals such as ID verification issues or patterns that may require closer review – all of which reduces the administrative load on clinicians so they can focus more on their interactions with patients.
On the patient-access side, AI-driven support systems are making a major difference. Tools that handle scheduling, rescheduling, reminders, and follow-up coordination eliminate a lot of the human bottlenecks that often delay care. They also help create a more standardized experience across large patient populations, which is critical when serving individuals with ADHD and anxiety who can be disproportionately affected by inconsistency or long wait times.
For underserved populations, these technologies can dramatically increase reach. When administrative tasks are automated and workflows are standardized, clinicians can serve more patients, wait times drop, and care becomes more affordable. My view is that the next wave of telehealth won’t be about replacing clinicians with AI – it will be about empowering clinicians with better operational tools so that high-quality mental health care becomes accessible to more people.